NCT05024214 2026-03-25Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors3D MedicinesPhase 1/2 Recruiting170 enrolled
NCT07159191 2025-09-08Envafolimab Combined With Axitinib as First-Line Treatment for Patients With Advanced Renal Cell CarcinomaPeking Union Medical College HospitalPhase 2 Not yet recruiting30 enrolled